Publication
Publication image

Market Access as the Key to Chinese Pharmaceuticals

Portrait of Yoshihiro Suwa
Senior Partner, Supervisory Board Member
Singapore Office, Southeast Asia
June 29, 2014

This study examines the Chinese pharmaceuticals market – a sector that has steadily posted solid and swift growth at an annual clip exceeding 20% in recent years.

1. China Already a Top Market

  • As of 2012, the Chinese pharmaceuticals market was No. 3 in the world. By 2020, it is expected to rise to No. 2.
  • The Chinese market in these products offers higher profitability than its counterparts in developed nations.

2. Shifting from “Sales-Driven Marketing” to “Market Access”

  • The end of the era of sales supported by quantitative superiority and sheer sales strength.
  • Meticulous market access to regional governments holds the key to success from here on.

3. Demands for Precision Market Grasp

  • Sizing up markets through local products.
  • Spot-on assessment of business opportunities.

blue background
Think:Act

Hiyaku: Market Access as the Key to Chinese Pharmaceuticals

{[downloads[language].preview]}

This study examines the Chinese pharmaceuticals market.

Published June 2014. Available in